Press releases

  • 2019-11-05

    For the first time in UK, a wider audience can get first-hand experience of the NeoNavia® micropulse biopsy system for breast cancer

    During the annual meeting of the British Society of Breast Radiology (BSBR) on 3-5th November in Bristol, radiologists get to gain first-hand experience using the innovative micropulse technology in meat models via a series of hands-on workshops arranged by NeoDynamics Read more
  • 2019-10-29

    NeoDynamics receives regulatory approval for new breast cancer biopsy system

    NeoDynamics today received confirmation from Intertek (Notified Body) that the improved version of the new system for breast cancer biopsy, NeoNavia, is accepted as an update to the already EU approved study version. The upgraded pulse biopsy system including three needle types, is added to the product list on the company’s EC certificate. Read more
  • 2019-09-16

    NeoDynamics recruits a country manager for Germany, Switzerland and Austria

    Renate Reiss takes over as Country Manager for NeoDynamics in the German-speaking countries in the EU, starting on 15 October. Renate has a broad international experience in product launches, from leading roles in the pharmaceutical industry. She will be responsible for the launch of NeoNavia, a brand new system for breast cancer tissue diagnosis. Read more
  • 2019-08-28

    NeoDynamics has secured financing through the issue of convertibles and calls for an Extraordinary General Meeting

    The Board of Directors of NeoDynamics AB (publ) ("NeoDynamics") or ("The Company") has decided to propose an issue of convertibles of up to SEK 15 million to strengthen the Company's cash and secure capital requirements prior to the start of production and clinical trials. The Board has therefore decided to convene an Extraordinary General Meeting on September 16. See attached notice (Swedish language) Read more
  • 2019-08-28

    NeoDynamics Half-year report 2019

    Approaching the market – registration in focus Read more
  • 2019-08-15

    New date for NeoDynamics semi-annual report 2019

    The Board of Directors of NeoDynamics AB (publ) has decided a new date for the publication of the semi-annual report 2019. The Report will be published on August 28, 2019.  Read more
  • 2019-05-22

    NeoDynamics AB (publ) invests in biopsy instrument for more effective sampling of suspected skin cancer

    NeoDynamics AB (publ) starts a joint venture, for the development of a new biopsy instrument for more effective tissue sampling of suspected skin cancer. Read more
  • 2019-05-21

    NeoDynamics AB (publ) - Quarterly report January-March 2019

    First quarter developed according to plan. Started development of a biopsy marker Read more